Possis Medical, Inc. Study Finds that Removing Large Thrombus Before Treatment with Drug-Eluting Stents Improves Outcomes in Heart Attack Patients

MINNEAPOLIS--(BUSINESS WIRE)--Possis Medical, Inc. (NASDAQ:POSS), a developer, manufacturer and marketer of pioneering medical devices used in endovascular procedures, today announced the formal publication of an important clinical study showing favorable results for AngioJet® thrombectomy treatment of heart attack patients with large thrombus (blood clot). The study shows that when AngioJet thrombectomy is used to remove large thrombus before placement of a drug-eluting stent (DES), it is associated with significantly lower rates of subsequent death, repeat heart attack and stent thrombosis. The work is authored by Dr. George Sianos and colleagues at the ThoraxCenter in Rotterdam, the Netherlands, and appears in the Journal of the American College of Cardiology (JACC), volume 50, number 7, dated August 14, 2007. The publication can be viewed on-line at http://content.onlinejacc.org.